Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

A Randomized, Double‐Blind, Placebo‐Controlled Trial of Abatacept for the Treatment of Relapsing, Nonsevere Granulomatosis With Polyangiitis

Arthritis & Rheumatology(2025)10.1002/art.43272Source: DataRank Database

A Randomized, Double‐Blind, Placebo‐Controlled Trial of Abatacept for the Treatment of Relapsing, Nonsevere Granulomatosis With Polyangiitis is a research paper published in Arthritis & Rheumatology (2025). On theSindex it has a DataRank of 0. It has been cited 8 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access8 citations

Download PDF

Cite:

Linked data & code

nct

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 6.24)OA: bronzeTopics (32)IDs (PubMed, PMC, OpenAlex)Annotations (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (30)

Nader Khalidi ORCID,Jason Springer ORCID,Marcia Friedman ORCID,Bernhard Hellmich ORCID,Christian Pagnoux ORCID

Live enrichment

PubMed:40506793 PMC:PMC12413890 OpenAlex:https://openalex.org/W4411295871

National Institutes of Health

Grant: U01 AR5187404

National Institutes of Health

Grant: U54 AR057319

National Institutes of Health

Grant: U54 RR019497

Bristol-Myers Squibb

Grant: IM101-446

FWCI

6.24

Citation Percentile

1.0%

Citation Trend

2025

2026

bronzeLicense: http://creativecommons.org/licenses/by-nc-nd/4.0/

journalhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/art.43272

publisherhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/art.43272

publisherhttps://acrjournals.onlinelibrary.wiley.com/doi/pdf/10.1002/art.43272

journalhttps://doi.org/10.1002/art.43272

repositoryhttps://pubmed.ncbi.nlm.nih.gov/40506793

Fields of Study

Vasculitis and related conditionsSystemic Sclerosis and Related DiseasesPeripheral Artery Disease Management

MeSH Terms

AbataceptAdultAgedDouble-Blind MethodDrug Therapy, CombinationFemaleGlucocorticoidsHumansImmunosuppressive AgentsMaleMiddle AgedPrednisoneRecurrenceRemission InductionGranulomatosis with PolyangiitisTreatment Outcome

Keywords

Granulomatosis with polyangiitisMedicineAbataceptDouble blindRandomized controlled trialPlaceboDermatologyInternal medicineVasculitisPathologyAlternative medicineDiseaseRituximab

A Randomized, Double‐Blind, Placebo‐Controlled Trial of Abatacept for the Treatment of Relapsing, Nonsevere Granulomatosis With Polyangiitis

FAIR Checklist

Authors (30)

Funding (4 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)